• Facebook
  • Instagram
  • Twitter
  • Home
  • Members
  • En Español
  • Contact
National Cancer Institute Clinical Oncology Research Program
SCOR - Southeast Clinical Oncology Research Consortium
  • Clinical Trials
  • Find a Doctor
  • About SCOR
    • Become a Member
  • Resources
    • Videos
    • Articles
    • Community Members
    • Community Support Groups
    • FAQs
    • Patient Resources
  • Menu Menu
  • Home
  • Members
  • En Español
  • Clinical Trials
  • Find a Clinical Trial Doctor
  • About SCOR
    • About SCOR
    • Become a Member of SCOR
  • Resources
    • Videos
    • News
    • Community Members
    • Community Support Groups
    • Clinical Trials FAQ
    • Clinical Trial Patient Resources
  • Contact SCOR
  • Privacy Policy
  • Site Map

Why are a lower percentage of cancer patients dying?

March 11, 2020/in Charlotte, Novant Health
‘Commitment from patients, physicians and policymakers throughout the country’
From Novant Healthy Headlines
By Cliff Mehrtens
March 10, 2020

The cancer mortality rate in America is dropping.

Merriman_Joseph_Head_web

Dr. Joseph Merriman

Cancer deaths have declined 29% in the past three decades, including a 2.2% drop in 2017, the largest single-year decline since recordkeeping began in 1930, according to the recent American Cancer Society annual statistics report.

“I hope it gives great hope that what we’re doing is making progress and moving the needle,” said Dr. Joseph Merriman, a medical oncologist at Novant Health Cancer Specialists – Charlotte. “The progress we see in this report reflects the commitment from patients, physicians and policymakers throughout the country, in addition to the science behind it.”

Merriman said several factors contribute to the decline:

  • Patients and communities are better informed.
  • Physicians can provide improved diagnostics and treatments, specifically in the care of patients with lung cancer and melanoma.
  • Fewer people are smoking.
  • More people are seeking appropriate screenings, such as mammograms, colonoscopies and low-dose computed tomography (CT) scans for lung cancer.
  • Advances have been made in targeted drugs and immunotherapy, which is the process of using a patient’s immune system to fight cancer.

“While we focus on and praise the research and therapies, we also have to credit those millions of selfless patients who have made this progress possible through participation in studies across the U.S.,” Merriman said.

Through clinical trials, doctors determine whether new treatments are safe and effective, and if they work better than current treatments. Clinical trials also help find new ways to prevent and detect cancer.

Talk with your doctor to determine if a clinical trial could be right for you. Call the Novant Health Oncology Research Institute in Charlotte (704-384-5369) or the Novant Health Clinical Research Institute in Winston-Salem (316-277-0910) to learn more about current trial participation opportunities.

Novant Health cancer patients and their caregivers will benefit from the new Edward I. and Agnes B. Weisiger Cancer Center, scheduled to open this fall.

“All these new treatments and innovations are only as good as they are accessible,” Merriman said. “Our focus is to bring the most innovative standard of care to the community locally. Charlotte is a robust community, so why not be able to offer the latest, whether it be optimizing the standard of care or a clinical trial or research for the community here?”

https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png 0 0 BCeditor https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png BCeditor2020-03-11 17:14:572020-06-03 17:18:38Why are a lower percentage of cancer patients dying?

Novant Health appoints vice president of research, innovation

March 30, 2019/in Charlotte, Novant Health, Winston Salem

By Jessica Kim Cohen
www.ModernHealthcare.com

Novant Health has named Mark J. King its vice president of research and innovation, effective March 11.

King joins Novant Health from the Winston-Salem, N.C.-based health system’s neighbor, Atrium Health. King serves as Atrium Health’s assistant vice president of research administration, where he oversees clinical trials and research operations. He will continue in that role until March.

King previously led development of oncology clinical trials as assistant vice president for the clinical trials office at Atrium Health’s Levine Cancer Institute.

At Novant Health, King will work with physician leaders across the 15-hospital system to improve patient access to clinical trials, according to a news release. He will work side-by-side with Dr. Steven Limentani, Novant Health’s senior vice president of oncology, to expand the health system’s clinical research portfolio and develop relationships with pharmaceutical companies and device manufacturers, as well as academic research centers.

Another component of King’s new role will involve helping Novant Health apply emerging technologies, such as artificial intelligence, to clinical research efforts.

King will report to Dr. Eric Eskioglu, executive vice president and chief medical officer of Novant Health.

“Mark has over 15 years of experience in furthering research and development through clinical trials with medical and healthcare systems,” Eskioglu said in a news release. “His depth of knowledge will be valuable in helping Novant Health continue to grow in the remarkable care we provide to our patients with expanded treatment options through advanced clinical research.”

https://southeastclinicaloncology.org/wp-content/uploads/2019/09/Novant-President.jpg 750 526 BCeditor https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png BCeditor2019-03-30 13:49:392019-09-04 13:50:28Novant Health appoints vice president of research, innovation

A program of the National Cancer Institute of the National Institutes of Health

Community Resources

FAQ's

Participating SCOR Members

  • Asheville, NC – Messino
  • Cary, NC
  • Charleston, SC
  • Charlotte, NC
  • Chesapeake, VA
  • Cookeville, TN
  • Florence, SC
  • Fort Myers, FL
  • Gastonia, NC
  • Goldsboro, NC
  • Greensboro, NC
  • Hendersonville, NC
  • Hendersonville, NC – Advent Health
  • Kingsport, TN
  • Martinsville, VA
  • New Bern, NC
  • Pinehurst, NC
  • Richmond, VA
  • Rocky Mount, NC
  • Savannah, GA
  • Wilmington, NC
  • Winston Salem, NC

Contact SCOR

Southeast Clinical Oncology
Research Consortium

2150 Country Club Road,
Suite 200
Winston Salem, NC 27104
T: (336) 448-1417
F: (336) 448-1425

Member Communities

Asheville, NC – Messino
Cary, NC
Charleston, SC
Charlotte, NC
Chesapeake, VA
Cookeville, TN
Florence, SC
Fort Myers, FL
Gastonia, NC
Goldsboro, NC
Greensboro, NC
Hampton Roads, VA
Hendersonville, NC – Pardee
Hendersonville, NC – AdventHealth
Kingsport, TN
Martinsville, VA
New Bern, NC
Pinehurst, NC
Richmond, VA
Rocky Mount, NC
Savannah, GA
Wilmington, NC
Winston-Salem, NC

National Cancer Institute Clinical Oncology Research Program, Grant #5UG1CA-189858. All content © Southeast Clinical Oncology Research Consortium. All rights reserved. 2150 Country Club Road, Suite 200, Winston-Salem, NC 27104-4241 | Phone: (336) 448-1417 | Fax: (336) 448-1425 | Site Map | Privacy Policy | Website Design by Built Creative.
  • Facebook
  • Instagram
  • Twitter
Scroll to top